William L. Boyko, Jr, PharmD | Authors


Performing Economic Evaluations Alongside of Cancer Clinical Trials

July 01, 1998

Health care providers and financing organizations have become more aware of the resource constraints on the provision of medical services, thus increasing the importance of economic evaluations within the health care industry.[1,2] This has carried over to the evaluation of new, therapeutic strategies for cancer, which have traditionally been evaluated exclusively for safety and clinical efficacy.